Human Vaccines & Immunotherapeutics,
Journal Year:
2023,
Volume and Issue:
19(3)
Published: Nov. 9, 2023
Intervertebral
disc
degeneration
is
an
important
pathological
basis
for
spinal
degenerative
diseases.
The
imbalance
of
the
immune
microenvironment
and
involvement
cells
has
been
shown
to
lead
nucleus
pulposus
death.
This
article
presents
a
bibliometric
analysis
studies
on
in
IDD
order
clarify
current
status
hotspots.
We
searched
WOSCC,
Scopus
PubMed
databases
from
01/01/2001
08/03/2023.
analyzed
visualized
content
using
software
such
as
Citespace,
Vosviewer
bibliometrix.
study
found
that
number
annual
publications
increasing
year
year.
journal
Spine
had
highest
articles
citations.
country/regions
showed
China
publications,
USA
citations
total
link
strength.
institutional
Shanghai
Jiao
Tong
University
Huazhong
Science
Technology
Tokai
citations,
Bern
Sakai
D
Risbud
MV
publications.
strength,
results
keyword
suggested
research
hotspots
future
directions
continue
be
mechanisms
IDD,
therapeutic
role
tissue
engineering
IDD.
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
98, P. 102323 - 102323
Published: May 9, 2024
Oxidative
stress
is
one
of
the
main
driving
mechanisms
intervertebral
disc
degeneration(IDD).
has
been
associated
with
inflammation
in
disc,
cellular
senescence,
autophagy,
and
epigenetics
cells.
It
above
pathological
are
closely
linked
through
common
hub
reactive
oxygen
species(ROS),
promote
each
other
process
degeneration
development
disease.
This
reveals
important
role
oxidative
IDD,
importance
great
potential
IDD
therapy
targeting
stress.
The
efficacy
traditional
unstable
or
cannot
be
maintained.
In
recent
years,
due
to
rise
materials
science,
many
bioactive
functional
have
applied
treatment
combination
drugs,
satisfactory
achieved.
At
present,
research
review
antioxidant
not
complete.
Based
on
existing
studies,
mechanism
were
summarized
this
paper,
strategies
based
emerging
reviewed.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1525 - 1525
Published: Jan. 26, 2024
Platelet
concentrates
such
as
platelet-rich
plasma,
fibrin
or
concentrated
growth
factors
are
cost-effective
autologous
preparations
containing
various
factors,
including
platelet-derived
factor,
transforming
factor
β,
insulin-like
1
and
vascular
endothelial
factor.
For
this
reason,
they
often
used
in
regenerative
medicine
to
treat
wounds,
nerve
damage
well
cartilage
bone
defects.
Unfortunately,
after
administration,
these
release
very
quickly,
which
lose
their
activity
rapidly.
As
a
consequence,
results
the
need
repeat
therapy,
is
associated
with
additional
pain
discomfort
for
patient.
Recent
research
shows
that
combining
platelet
biomaterials
overcomes
problem
because
released
more
sustainable
manner.
Moreover,
concept
fits
into
latest
trends
tissue
engineering,
include
biomaterials,
bioactive
cells.
Therefore,
review
presents
literature
reports
on
properties
of
enriched
applications
skin,
nerve,
engineering.
Periodontology 2000,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 10, 2024
Abstract
Platelet‐rich
plasma
(PRP)
is
the
platelet
and
leukocyte‐containing
plasmatic
fraction
of
anticoagulated
autologous
blood.
While
evidence
supporting
clinical
use
PRP
in
dentistry
low,
widely
used
sports
medicine,
orthopedics,
dermatology.
Its
beneficial
activity
commonly
attributed
to
growth
factors
released
from
platelets
accumulating
PRP;
however,
indirect
not
comprehensive.
There
thus
a
demand
revisit
with
respect
basic
translational
science.
This
review
(i)
recapitulate
protocols
tools
prepare
(ii)
discuss
cellular
molecular
composition
focus
on
platelets,
leukocytes,
fibrin‐rich
extracellular
matrix
coagulated
plasma;
finally
(iii)
potential
effects
level
an
outlook
its
current
other
medical
fields.
Bioengineering,
Journal Year:
2023,
Volume and Issue:
10(8), P. 987 - 987
Published: Aug. 21, 2023
Aging
and
age-related
changes
impact
the
quality
of
life
(QOL)
in
elderly
with
a
decline
movement,
cognitive
abilities
increased
vulnerability
towards
diseases
(ARDs).
One
key
contributing
factors
is
cellular
senescence,
which
triggered
majorly
by
DNA
damage
response
(DDR).
Accumulated
senescent
cells
(SCs)
release
senescence-associated
secretory
phenotype
(SASP),
includes
pro-inflammatory
cytokines,
matrix
metalloproteinases
(MMPs),
lipids
chemokines
that
are
detrimental
to
surrounding
tissues.
Chronic
low-grade
inflammation
or
inflammaging
also
associated
senescence
contributes
ARDs.
The
literature
from
last
decade
has
recorded
use
platelet
rich
plasma
(PRP)
combat
inflammation,
alleviate
pain
as
an
analgesic,
promote
tissue
regeneration
repair
via
angiogenesis—all
essential
anti-aging
strategies.
In
few
decades,
platelet-rich
been
used
treatment
option
for
dermatological
applications
great
interest
orthopaedic
applications,
especially
osteoarthritis
(OA).
this
exploration,
we
connect
intricate
relationship
between
aging,
ARDs,
delve
into
PRP’s
properties
potential
benefits.
We
conduct
comparative
review
current
on
PRP
strategies,
paying
particular
attention
instances
strongly
linked
Finally,
upon
careful
consideration
interconnected
information
context
suggest
prospective
role
developing
therapeutic
Experimental Biology and Medicine,
Journal Year:
2025,
Volume and Issue:
250
Published: Feb. 4, 2025
The
current
meta-analysis
was
performed
to
analyze
the
efficacy
and
safety
of
platelet-rich
plasma
(PRP)
as
an
epidural
injectate,
in
comparison
with
steroids
management
radiculopathy
due
lumbar
disc
disease
(LDD).
We
conducted
independent
duplicate
searches
electronic
databases
(PubMed,
Embase
Cochrane
Library)
March
2024
identify
randomized
controlled
trials
(RCTs)
analyzing
PRP
for
pain
relief
LDD.
Animal
or
vitro
studies,
clinical
studies
without
a
comparator
group,
retrospective
non-randomised
were
excluded.
Diverse
post-intervention
scores
[visual
analog
score
(VAS)]
functional
[Oswestry
Disability
Index
(ODI),
SF-36],
reported
reviewed
evaluated.
Statistical
analysis
using
STATA
17
software.
5
RCTs
including
310
patients
(PRP/Steroids
=
153/157)
included
analysis.
compared
at
various
time-points
1,
3,
6,
12,
24,
48
weeks.
Epidural
injection
found
offer
comparable
(VAS;
WMD
−0.09,
95%
CI
[−0.66,
0.47],
p
0.641;
I
2
96.72%,
<
0.001),
improvement
(ODI;
0.72,
[-6.81,
8.25],
0.524;
98.73%,
overall
health
(SF-36;
1.01,
[−1.14,
3.17],
0.224;
0.0%,
0.36)
steroid
(ESI)
all
observed
time
points
any
increase
adverse
events
complications.
administration
offers
benefit
profile
is
also
similar
ESI.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 23, 2025
Degenerative
disc
disease
is
a
common
disorder
that
can
significantly
impact
patients'
quality
of
life,
leading
to
chronic
pain
and
disability.
Platelet-rich
plasma
(PRP)
therapy
emerging
as
potential
treatment
for
degenerative
disease.
The
purpose
this
review
summarize
the
role
PRP
in
management
types
III
IV.
This
scoping
literature
review.
online
database
PUBMED
was
used,
papers
were
searched
using
keywords:
("PRP"
OR
"platelet-rich
plasma")
AND
("degenerative
disk
disease"
"disk
degeneration"
"intradiscal
injection"
"discogenic
pain"
"intervertebral
"degenerative
disease").
Clinical
studies
evaluating
stage
IV
included
study.
Systematic
reviews,
animal
studies,
vitro
case
reports,
study
designs,
languages
other
than
English
excluded.
present
includes
14
studies.
has
been
found
promote
tissue
regeneration
modulate
inflammatory
response
degenerated
discs.
be
administered
mostly
intradiscally
but
also
epidurally.
benefits
use
include
reduction,
improvement
functionality,
low
risk
adverse
events.
effect
intradiscal
injections
similar
steroid
injections.
A
higher
concentration
platelets
associated
with
enhanced
clinical
outcomes.
represents
promising
avenue
healing
across
While
evidence
supporting
its
efficacy
encouraging,
further
research
needed
elucidate
mechanisms
action,
optimize
protocols,
expand
applications.
Journal of Orthopaedic Surgery and Research,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: March 25, 2025
Although
epidural
corticosteroid
injections
(ESIs)
provide
short-term
relief
for
lumbar
radicular
pain
caused
by
disc
herniation,
concerns
remain
regarding
their
long-term
efficacy
and
complications.
Platelet-rich
plasma
(PRP),
with
its
dual
anti-inflammatory
regenerative
properties,
is
a
promising
alternative,
but
the
comparative
evidence
between
two
treatments
remains
inconclusive.
A
systematic
search
was
conducted
in
PubMed,
Embase,
Web
of
Science,
Cochrane
Library,
cutoff
date
January
10,
2025.
The
primary
outcomes
were
Visual
Analog
Scale
(VAS)
Oswestry
Disability
Index
(ODI)
scores.
risk
bias
included
studies
assessed
using
ROB
ROBINS-I.
outcome
measures
analyzed
evaluating
standardized
mean
differences
(SMDs).
total
seven
(four
randomized
controlled
trials
three
prospective
studies)
meta-analysis,
comprising
416
patients.
results
indicated
that
corticosteroids
significantly
reduced
ODI
scores
at
initial
follow-up
(4
weeks)
(SMD
=
0.48,
95%
CI:
0.20
to
0.75,
p
0.0008,
I²
15%),
no
significant
observed
VAS
groups
other
time
points.
complication
rates
PRP
reported,
severe
adverse
events
reported.
Compared
PRP,
showed
early
functional
improvements
points,
future
are
needed
assess
safety
versus
treating
standardizing
preparation,
extending
durations,
increasing
sample
sizes.